Isolated endogenous endophthalmitis due to a sporodochial-forming Phialemonium curvatum acquired through intracavernous autoinjections

Medical Mycology

Volumn 44, Issue 3, 2006, Pages 253-259

  Weinberger, Miriam ^a,e,f   Mahrshak, I ^a,e   Keller, N ^b,e   Goldscmied Reuven, A ^b,e   Amariglio, N ^b,e   Kramer, M ^a,e   Tobar, A ^a,e   Samra, Z ^a,e   Pitlik, S D ^a,e   Rinaldi, M G ^c,d   Thompson, E ^c   Sutton, D ^c  

^a RABIN MEDICAL CENTER   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c Mays Cancer Center at UT Health San Antonio   (United States)

^d SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^e TEL AVIV UNIVERSITY   (Israel)

^f ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

Contamination; Endophthalmitis; Injections; Outbreak; Phialemonium curvatum

Indexed keywords

AGENTS ACTING ON THE GENITAL SYSTEM; AMPHOTERICIN B; ANTIBIOTIC AGENT; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; FUNGAL DNA; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE;

ACREMONIUM; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; CASE REPORT; CLINICAL FEATURE; ENDOPHTHALMITIS; ENUCLEATION; ERECTILE DYSFUNCTION; FUNGAL MORPHOLOGY; FUNGUS; FUNGUS ISOLATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPHOMYCETES; ISRAEL; MALE; MICROBIOLOGICAL EXAMINATION; MYCOSIS; NUCLEOTIDE SEQUENCE; PHIALEMONIUM CURVATUM; SELF INJECTION; SPECIES DIFFERENCE; VOLUTELLA;

AGED; ASCOMYCOTA; ENDOPHTHALMITIS; EYE INFECTIONS, FUNGAL; HUMANS; IMPOTENCE; INJECTIONS; MALE; PENIS; SELF ADMINISTRATION;

ACREMONIUM (ASCOMYCOTA); FUNGI; HYPHOMYCETES; PHIALEMONIUM; PHIALEMONIUM CURVATUM; VOLUTELLA;

EID: 33646843768     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780500411097     Document Type: Article

References (30)

1. Benz, MS and Scott, IU and Flynn, HW, Jr and Unonius, N and Miller, D. (2004) Endophthalmitis isolates and antibiotic sensitivities: A 6-year review of culture-proven cases Am J Ophthalmol, 137, pp. 38-42.
2. BinderMI, ChuaJ, KaiserPK, ProcopGW, IsadaCM. Endogenous endophthalmitis: An 18-year review of culture-positive cases at a tertiary care center. Medicine (Baltimore)2003; 82: 97-105.
3. Feman, SS and Nichols, JC and Chung, SM and Theobald, TA. (2002) Endophthalmitis in patients with disseminated fungal disease Trans Am Ophthalmol Soc, 100, pp. 67-70.
4. Klotz, SA and Penn, CC and Negvesky, GJ and Butrus, SI. (2000) Fungal and parasitic infections of the eye Clin Microbiol Rev, 13, pp. 662-685.
5. Tanaka, M and Kobayashi, Y and Takebayashi, H and Kiyokawa, M and Qiu, H. (2001) Analysis of predisposing clinical and laboratory findings for the development of endogenous fungal endophthalmitis. A retrospective 12-year study of 79 eyes of 46 patients Retina, 21, pp. 203-209.
6. Kim, RW and Juzych, MS and Eliott, D. (2002) Ocular manifestations of injection drug use Infect Dis Clin North Am, 16, pp. 607-622.
7. Gupta, A and Gupta, V and Dogra, MR et al (2000) Fungal endophthalmitis after a single intravenous administration of presumably contaminated dextrose infusion fluid Retina, 20, pp. 262-268.
8. Strahilevitz, J and Rahav, G and Schroers, HJ et al (2005) An outbreak of Phialemonium infective endocarditis linked to intracavernous penile injections for the treatment of impotence Clin Infect Dis, 40, pp. 781-786.
9. CiobotaroP, StrahilewitzJ, Sigma-IgraY,. An outbreak of Phialemonium curvatum (P.c) infections in patients with erectile dysfunction. 43rd Interscience Conference on Antimicroial. Agents and Chemotherapy, Chicago, 14-17 September2003: Abstr. K-1431.
10. Rinaldi, MG. (1982) Use of potato flakes agar in clinical mycology J Clin Microbiol, 15, pp. 1159-1160.
11. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard. NCCLS document M38-A. National Committee for Clinical Laboratory Standards: WaynePA. 2002.
12. Arikan, S and Lozano-Chiu, M and Paetznick, V and Rex, JH. (2001) In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates Antimicrob Agents Chemother, 45, pp. 327-330.
13. Kurtz, MB and Heath, IB and Marrinan, J et al (1994) Morphological effect of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase Antimicrob Agents Chemother, 38, pp. 1480-1489.
14. White, TJ and Bruns, T and Lee, SJT.(1990) Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In A Guide to Methods and Applications. (pp. 315-322). San Diego: Academic Press.
15. Guarro, J and Nucci, M and Akiti, T et al (1999) Phialemonium fungemia: two documented nosocomial cases J Clin Microbiol, 37, pp. 2493-2497.
16. Gams, W and McGinnis, MR. (1983) Phialemonium, a new anamorph genus intermediate between Phialophora and Acremonium Mycologia, 75, pp. 977-987.
17. King, D and Pasarell, L and Dixon, DM and McGinnis, MR and Merz, WG. (1993) A phaeohyphomycotic cyst and peritonitis caused by Phialemonium species and a reevaluation of its taxonomy J Clin Microbiol, 31, pp. 1804-1810.
18. Proia, LA and Hayden, MK and Kammeyer, PL and (2004) Phialemonium: An emerging mold pathogen that caused 4 cases of hemodialysis-associated endovascular infection Clin Infect Dis, 39, pp. 373-379.
19. Gavin, PJ and Sutton, DA and Katz, BZ. (2002) Fatal endocarditis in a neonate caused by the dematiaceous fungus Phialemonium obovatum: Case report and review of the literature J Clin Microbiol, 40, pp. 2207-2212.
20. Heins-Vaccari, EM and Machado, CM and Saboya, RS and (2001) Phialemonium curvatum infection after bone marrow transplantation Rev Inst Med Trop Sao Paulo, 43, pp. 163-166.
21. Magnon, KC and Jalbert, M and Padhye, AA. (1993) Osteolytic phaeohyphomycosis caused by Phialemonium obovatum Arch Pathol Lab Med, 117, pp. 841-843.
22. McGinnis, MR and Gams, W and Goodwin, MN, Jr. (1986) Phialemonium obovatum infection in a burned child J Med Vet Mycol, 24, pp. 51-55.
23. Schonheyder, HC and Jensen, HE and Gams, W and (1996) Late bioprosthetic valve endocarditis caused by Phialemonium aff. curvatum and Streptococcus sanguis: A case report J Med Vet Mycol, 34, pp. 209-214.
24. Lakin, MM and Montague, DK and VanderBrug Medendorp, S and Tesar, L and Schover, LR. (1990) Intracavernous injection therapy: Analysis of results and complications J Urol, 143, pp. 1138-1141.
25. Leungwattanakij, S and Flynn, V, Jr and Hellstrom, WJ. (2001) Intracavernosal injection and intraurethral therapy for erectile dysfunction Urol Clin North Am, 28, pp. 343-354.
26. Parfitt, VJ and Wong, R and Dobbie, A and Hartog, M and Gingell, JC. (1992) Staphylococcal septicaemia complicating intracavernosal autoinjection therapy for impotence in a man with diabetes Diabet Med, 9, pp. 947-949.
27. Schwarzer, JU and Hofmann, R. (1991) Purulent corporeal cavernositis secondary to papaverine-induced priapism J Urol, 146, pp. 845-846.
28. Biswas, J. (2001) Fungal endophthalmitis after a single intravenous administration of presumably contaminated dextrose infusion fluid Retina, 21, pp. 93-94.
29. Anonymous. Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy - United States, July-November 2002. Morb Mortal Wkly Rep 2002; 51: 1109-1112.
30. Shankland, GS and Richardson, MD. (1988) Epidemiology of an outbreak of Candida endophthalmitis in heroin addicts: Identification of possible source of infection by biotyping J Med Vet Mycol, 26, pp. 199-202.